2002
DOI: 10.1590/s0036-46652002000200011
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: How long will last that syndrome? Who are at risk to develop this syndrome? Would it be better to start antiretroviral treatment concomitantly with anti-tuberculous drugs rather then in a later stage? A longer casuistic is necessary to evaluate the predictive factors and to clarify other questions in order to guide Brazilian and other underdeveloped countries' physicians in dealing with these non-desirable effects of HAART.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2009
2009
2019
2019

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(3 citation statements)
references
References 4 publications
0
3
0
Order By: Relevance
“…It has been used in isolated cases of IRIS: its use was associated with transient clinical improvement in a patient with TB lymphadenitis IRIS [36] and resolution of Cryptococcus lymphadenitis IRIS [18].…”
Section: Thalidomidementioning
confidence: 99%
“…It has been used in isolated cases of IRIS: its use was associated with transient clinical improvement in a patient with TB lymphadenitis IRIS [36] and resolution of Cryptococcus lymphadenitis IRIS [18].…”
Section: Thalidomidementioning
confidence: 99%
“…It has already been effectively used in Kaposi sarcoma, aphthous ulcers, gastrointestinal lesions and cryptococcal meningitis in HIV patients. Thalidomide has been also used in isolated cases of IRIS such as tuberculosis IRIS [12,13] and cryptococcus lymphadenitis IRIS [14]. Thalidomide may be a salvage treatment in patients with corticosteroid-dependent or refractory IRIS [15].…”
Section: Discussionmentioning
confidence: 99%
“…2 Thalidomide, which exhibits in vitro inhibition of TNF-α production, has been used in isolated cases of IRIS with tuberculosis and cryptococcal lymphadenitis. 68 Herein, we report two cases of IRIS in HIV-infected patients treated with thalidomide.…”
Section: Introductionmentioning
confidence: 97%